More than 5 million people have Alzheimer’s disease. 1 million people are living with Parkinson’s disease 20,000 people have Amyotrophic Lateral Sclerosis (ALS). Neurodegnerative diseases seem to be growing with no cures in sight.
But as dismal as this prognosis seems, there is hope and new approaches taking root. We talk to Katja Brose, neuroscientist and Science Program Officer at the Chan Zuckerberg Science Initiative about the latest, best prospects in neurodegenerative research.